274 related articles for article (PubMed ID: 22380010)
1. Nano-based drug delivery system enhances the oral absorption of lipophilic drugs with extensive presystemic metabolism.
Zhang Z; Gao F; Jiang S; Ma L; Li Y
Curr Drug Metab; 2012 Oct; 13(8):1110-8. PubMed ID: 22380010
[TBL] [Abstract][Full Text] [Related]
2. Presystemic extraction: mechanisms and consequences.
Greenblatt DJ
J Clin Pharmacol; 1993 Jul; 33(7):650-6. PubMed ID: 8366190
[TBL] [Abstract][Full Text] [Related]
3. Influence of food intake on presystemic clearance of drugs.
Melander A; McLean A
Clin Pharmacokinet; 1983; 8(4):286-96. PubMed ID: 6352137
[TBL] [Abstract][Full Text] [Related]
4. Presystemic metabolism of orally administered peptide drugs and strategies to overcome it.
Bernkop-Schnürch A; Schmitz T
Curr Drug Metab; 2007 Jun; 8(5):509-17. PubMed ID: 17584022
[TBL] [Abstract][Full Text] [Related]
5. Lipid-Based Nanocarriers for Lymphatic Transportation.
Vishwakarma N; Jain A; Sharma R; Mody N; Vyas S; Vyas SP
AAPS PharmSciTech; 2019 Jan; 20(2):83. PubMed ID: 30673895
[TBL] [Abstract][Full Text] [Related]
6. Nanocarriers: a general strategy for enhancement of oral bioavailability of poorly absorbed or pre-systemically metabolized drugs.
Cai Z; Wang Y; Zhu LJ; Liu ZQ
Curr Drug Metab; 2010 Feb; 11(2):197-207. PubMed ID: 20384585
[TBL] [Abstract][Full Text] [Related]
7. Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs.
Porter CJ; Trevaskis NL; Charman WN
Nat Rev Drug Discov; 2007 Mar; 6(3):231-48. PubMed ID: 17330072
[TBL] [Abstract][Full Text] [Related]
8. Potential of Liposomes for Enhancement of Oral Drug Absorption.
Daeihamed M; Dadashzadeh S; Haeri A; Akhlaghi MF
Curr Drug Deliv; 2017; 14(2):289-303. PubMed ID: 26768542
[TBL] [Abstract][Full Text] [Related]
9. Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies.
Wagle SR; Kovacevic B; Walker D; Ionescu CM; Shah U; Stojanovic G; Kojic S; Mooranian A; Al-Salami H
Expert Opin Drug Deliv; 2020 Oct; 17(10):1361-1376. PubMed ID: 32597249
[TBL] [Abstract][Full Text] [Related]
10. The Interplay Between Liver First-Pass Effect and Lymphatic Absorption of Cannabidiol and Its Implications for Cannabidiol Oral Formulations.
Franco V; Gershkovich P; Perucca E; Bialer M
Clin Pharmacokinet; 2020 Dec; 59(12):1493-1500. PubMed ID: 32785853
[TBL] [Abstract][Full Text] [Related]
11. Self-nano-emulsifying drug delivery systems: an update of the biopharmaceutical aspects.
Cherniakov I; Domb AJ; Hoffman A
Expert Opin Drug Deliv; 2015 Jul; 12(7):1121-33. PubMed ID: 25556987
[TBL] [Abstract][Full Text] [Related]
12. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
Dahan A; Hoffman A
J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
[TBL] [Abstract][Full Text] [Related]
13. Novel formulation strategies for improving oral bioavailability of drugs with poor membrane permeation or presystemic metabolism.
Aungst BJ
J Pharm Sci; 1993 Oct; 82(10):979-87. PubMed ID: 8254497
[TBL] [Abstract][Full Text] [Related]
14. Targeting the intestinal lymphatic system: a versatile path for enhanced oral bioavailability of drugs.
Managuli RS; Raut SY; Reddy MS; Mutalik S
Expert Opin Drug Deliv; 2018 Aug; 15(8):787-804. PubMed ID: 30025212
[TBL] [Abstract][Full Text] [Related]
15. Diverse approaches for the enhancement of oral drug bioavailability.
Fasinu P; Pillay V; Ndesendo VM; du Toit LC; Choonara YE
Biopharm Drug Dispos; 2011 May; 32(4):185-209. PubMed ID: 21480294
[TBL] [Abstract][Full Text] [Related]
16. Polymeric nanoparticles for oral delivery of drugs and vaccines: a critical evaluation of in vivo studies.
Galindo-Rodriguez SA; Allemann E; Fessi H; Doelker E
Crit Rev Ther Drug Carrier Syst; 2005; 22(5):419-64. PubMed ID: 16313233
[TBL] [Abstract][Full Text] [Related]
17. Experimental models for predicting drug absorption and metabolism.
Alqahtani S; Mohamed LA; Kaddoumi A
Expert Opin Drug Metab Toxicol; 2013 Oct; 9(10):1241-54. PubMed ID: 23687990
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic model of presystemic metabolism.
Colburn WA; Gibaldi M
Drug Metab Dispos; 1978; 6(2):193-6. PubMed ID: 26536
[TBL] [Abstract][Full Text] [Related]
19. Nanocrystals for Improving Oral Bioavailability of Drugs: Intestinal Transport Mechanisms and Influencing Factors.
Tian Z; Mai Y; Meng T; Ma S; Gou G; Yang J
AAPS PharmSciTech; 2021 Jun; 22(5):179. PubMed ID: 34128132
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
[Next] [New Search]
